Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Cognitive Complications 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Endometrial Neoplasms 1Emergence Delirium 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 8Radiotherapy 5Paclitaxel 5Docetaxel 5Cetuximab 4Carboplatin 4pembrolizumab 3figitumumab 2cemiplimab 2advexin 2Radiation 2Methotrexate 2Fluorouracil 2Drug Therapy 2Bleomycin 2vandetanib 1talimogene laherparepvec 1sintilimab 1nedaplatin 1nanocis 1methyl 5-aminolevulinate 1ficlatuzumab 1dusquetide 1brigatinib 1avasopasem manganese 1alpha-2'-deoxythioguanosine 1Vinorelbine 1Tretinoin 1Tirapazamine 1Technetium-99 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Squamous Cell × Control Groups × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡